$26.41 +$0.54 (+2.09%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $27.00 +2.23%
开盘$26.07
昨收$25.87
当日区间$25.84 – $26.77
成交量1.98M
市值$2.73B
市盈率（TTM）–
股息率–
BEAM 相关新闻
匹配 Beam Therapeutics 或代码 BEAM 的头条新闻，按最新排序。
- JonesTrading Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $35
- A Quick Look at Today's Ratings for Beam Therapeutics(BEAM.US), With a Forecast Between $35 to $80
- H.C. Wainwright Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $80
- Shimizu has added a 1.5-hour fire-resistant specification to its Hi-Wood Beam product lineup.
- J.P. Morgan Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Announces Target Price $44
- A Quick Look at Today's Ratings for Beam Therapeutics(BEAM.US), With a Forecast Between $43 to $78
- A Quick Look at Today's Ratings for Beam Therapeutics(BEAM.US), With a Forecast Between $35 to $78
- Freedom Capital Markets Downgrades Beam Global(BEEM.US) to Hold Rating, Maintains Target Price $1.5 负面
- Maxim Group Maintains Beam Global(BEEM.US) With Buy Rating, Cuts Target Price to $3 负面
- BofA Securities Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $47
- HC Wainwright & Co. Reiterates Buy on Beam Therapeutics, Maintains $80 Price Target
- 4: Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Evans John M.
- Freedom Capital Markets Initiates Beam Global(BEEM.US) With Buy Rating, Announces Target Price $1.5
- Wells Fargo Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $70
- Wedbush Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $65
暂无评论——快来第一个聊聊 BEAM。
登录后参与讨论。